Individualized Medicine - Ethical, Economical and Historical Perspectives (Hardcover, 2015 ed.)


In 2009 the University Medicine Greifswald launched the "Greifswald Approach to Individualized Medicine" (GANI_MED) to implement biomarker-based individualized diagnostic and therapeutic strategies in clinical settings. Individualized Medicine (IM) has led not only to controversies about its potentials, but also about its societal, ethical and health economic implications. This anthology focusses on these areas and includes - next to clinical examples illustrating how the integrated analysis of biomarkers leads to significant improvement of therapeutic outcomes for a subgroup of patients - chapters about the definition, history and epistemology of IM. Additionally there is a focus on conceptual philosophical questions as well as challenges for applied research ethics (informed consent process, the IT-based consent management and the handling of incidental findings). Finally it pays attention to health economic aspects. The possibilities of IM to initiate a paradigm shift in the German health care provision are investigated. Furthermore, it is asked whether the G-DRG system is ready for the implementation of such approaches into clinical routine.

R5,004
List Price R5,434
Save R430 8%

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles50040
Mobicred@R469pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days



Product Description

In 2009 the University Medicine Greifswald launched the "Greifswald Approach to Individualized Medicine" (GANI_MED) to implement biomarker-based individualized diagnostic and therapeutic strategies in clinical settings. Individualized Medicine (IM) has led not only to controversies about its potentials, but also about its societal, ethical and health economic implications. This anthology focusses on these areas and includes - next to clinical examples illustrating how the integrated analysis of biomarkers leads to significant improvement of therapeutic outcomes for a subgroup of patients - chapters about the definition, history and epistemology of IM. Additionally there is a focus on conceptual philosophical questions as well as challenges for applied research ethics (informed consent process, the IT-based consent management and the handling of incidental findings). Finally it pays attention to health economic aspects. The possibilities of IM to initiate a paradigm shift in the German health care provision are investigated. Furthermore, it is asked whether the G-DRG system is ready for the implementation of such approaches into clinical routine.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Springer International Publishing AG

Country of origin

Switzerland

Series

Advances in Predictive, Preventive and Personalised Medicine, 7

Release date

March 2015

Availability

Expected to ship within 12 - 17 working days

First published

2015

Editors

, , ,

Dimensions

235 x 155 x 25mm (L x W x T)

Format

Hardcover

Pages

323

Edition

2015 ed.

ISBN-13

978-3-319-11718-8

Barcode

9783319117188

Categories

LSN

3-319-11718-1



Trending On Loot